Drug lookup
Drug reference

phentolamine

Nonselective α adrenergic receptor antagonist (competitive) · Antihypertensive, Alpha Blocker

Nonselective α adrenergic receptor antagonist (competitive)Antihypertensive, Alpha BlockerATC C04AB01
CDSCO approvedATC C04AB01
EXCRETION
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
C
FDA category + note
Top interactionssee all 12
  • TizanidineSevereDatabaseDDInter

Mechanism

Phentolamine is a competitive α adrenergic receptor antagonist. It causes a progressive decrease in peripheral resistance due to antagonism of α adrenergic receptors in the vasculature and increases cardiac output due to reflex sympathetic stimulation and enhanced norepinephrine release (due to presynaptic α2 blockade).

Indications

hypertension (short-term control in pheochromocytoma)relieving pseudo-obstruction of bowel (in pheochromocytoma)prevent dermal necrosis after extravasation of α receptor agonisthypertensive crises (after clonidine withdrawal, tyramine-containing foods with MAOIs)sexual dysfunction (buccal or oral for some men)reversing soft tissue local anesthesiaDiagnosis of pheochromocytomaIntraoperative management of pheochromocytomaControl of hypertension due to clonidine withdrawalControl of hypertension due to cheese reactionCounteracting vasoconstriction due to extravasated NA/DA during their i.v. infusionerectile dysfunction (ED) (as part of intracavernosal injection therapy)Hypertensive episodes in pheochromocytomaCheese reactionClonidine withdrawal

Dosing

Adult
5 mg i.v. repeated as required

Pharmacokinetics

Onset
2 min
Duration
5–15 min

Contraindications

  • history of peptic ulcer (use with caution)

Side effects

Common
hypotensionreflex tachycardiacardiac arrhythmiasreversible inhibition of ejaculationgastric acid secretion
Serious
  • severe hypotension (rapid infusions)
  • cardiac ischemic events (including myocardial infarction)
  • Tachycardia (may complicate use)
  • myocardial ischaemia (may complicate use)

Pregnancy & lactation

Pregnancy

C

Drug interactions

Tizanidine
Severe
Database

Clinical effect not specified

Source: DDInter

Acebutolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Atenolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Betaxolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Bisoprolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Bucindolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Carteolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Carvedilol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Celiprolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Esmolol Hydrochloride
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Esmolol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Labetalol
Moderate
Textbook

Management of tachycardia caused by phentolamine.

A beta blocker may be added with phentolamine.

Source: KDT 7e · p573

Related guidelines

Ask House about phentolamine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team